Literature DB >> 1575973

Right hemisphere sensitivity to arousal and depression.

M Liotti1, D M Tucker.   

Abstract

Several lines of evidence show impaired right hemisphere function in depression. Lateralized simple reaction time tasks show impaired left visual field responses both in normals experiencing a depressed mood and in patients with mild unipolar depression. One interpretation for these findings is that depression impairs right hemisphere function by interfering with right hemisphere arousal and vigilance mechanisms. In order to test this hypothesis, subjects receiving either depression or relaxation mood suggestions performed an uncued reaction time task that has been shown to be sensitive to right posterior brain damage. Level of alertness was varied by contrasting uncued blocks with blocks in which targets were preceded by a warning tone. The results showed the predicted slowing of left visual field responses in the depressed mood, but only in women. The effect was significant only for the uncued blocks. The left visual field impairment was significantly larger during depression than in the relaxation state, but a smaller left visual field slowing was present in women in the relaxed state as well. These results may be consistent with the notion that depression interferes with right hemisphere function in part by influencing right hemisphere arousal mechanisms.

Entities:  

Mesh:

Year:  1992        PMID: 1575973     DOI: 10.1016/0278-2626(92)90075-w

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  13 in total

Review 1.  Emotion and pain: a functional cerebral systems integration.

Authors:  Gina A Mollet; David W Harrison
Journal:  Neuropsychol Rev       Date:  2006-09-28       Impact factor: 7.444

2.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 3.  Parkinson's disease as a disconnection syndrome.

Authors:  Alice Cronin-Golomb
Journal:  Neuropsychol Rev       Date:  2010-04-10       Impact factor: 7.444

4.  Luxotonic signals in human prefrontal cortex as a possible substrate for effects of light on mood and cognition.

Authors:  Shai Sabbah; Michael S Worden; Dimitrios D Laniado; David M Berson; Jerome N Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-06       Impact factor: 12.779

5.  Post-stroke depression: relationships with morphological damage and cognition over time.

Authors:  M Iacoboni; A Padovani; V Di Piero; G L Lenzi
Journal:  Ital J Neurol Sci       Date:  1995-05

6.  An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder.

Authors:  Paul B Fitzgerald; Anusha Srithiran; Jessica Benitez; Zafiris Z Daskalakis; Tom J Oxley; Jayashri Kulkarni; Gary F Egan
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

7.  Psychomotor Retardation, Attention Deficit and Executive Dysfunctional in Young Non-hospitalised Un-medicated Non-psychotic Unipolar Depression Patients.

Authors:  Kamini Ramdas Ilamkar
Journal:  J Clin Diagn Res       Date:  2014-02-03

8.  Alertness and visuospatial attention in clinical depression.

Authors:  Lisa Schock; Michael Schwenzer; Walter Sturm; Klaus Mathiak
Journal:  BMC Psychiatry       Date:  2011-05-09       Impact factor: 3.630

9.  Mood modulates auditory laterality of hemodynamic mismatch responses during dichotic listening.

Authors:  Lisa Schock; Miriam Dyck; Liliana R Demenescu; J Christopher Edgar; Ingo Hertrich; Walter Sturm; Klaus Mathiak
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

10.  Assessing the molecular genetics of attention networks.

Authors:  John Fossella; Tobias Sommer; Jin Fan; Yanhong Wu; James M Swanson; Donald W Pfaff; Michael I Posner
Journal:  BMC Neurosci       Date:  2002-10-04       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.